Team:Imperial College/Modelling beta-amyloid

From 2013.igem.org

(Difference between revisions)
(Created page with "{{:Team:Imperial_College/Templates:header}} <h1>Modelling beta-amyloid</h1> Modelling collaboration with UCL {{:Team:Imperial_College/Templates:footer}}")
Line 1: Line 1:
{{:Team:Imperial_College/Templates:header}}
{{:Team:Imperial_College/Templates:header}}
-
<h1>Modelling beta-amyloid</h1>
+
<h1>Modelling Beta-Amyloid</h1>
-
 
+
-
Modelling collaboration with UCL
+
 +
This is another degradation model we designed to help UCL with their Beta-Amyloid degradation assays. <a href="https://2013.igem.org/Team:UCL/Project/Degradation" target="_blank">Beta-Amyloid Degradation Assays </a> Beta-Amyloid is known as the component of Amyloids Plaque in association with Alzheimer's disease, in which the target of UCL iGEM this year <a href="https://2013.igem.org/Team:UCL/Background/Alzheimers" target="_blank">Alzheimer's disease (AD)</a>. Matrix metallopeptidase 9 (MMP-9) was discovered to degrade Beta-Amyloid that can be potentially used to cure Alzheimer's disease.
 +
{{:Team:Imperial_College/Templates:footer}}
{{:Team:Imperial_College/Templates:footer}}

Revision as of 19:05, 30 September 2013

Modelling Beta-Amyloid

This is another degradation model we designed to help UCL with their Beta-Amyloid degradation assays. <a href="https://2013.igem.org/Team:UCL/Project/Degradation" target="_blank">Beta-Amyloid Degradation Assays </a> Beta-Amyloid is known as the component of Amyloids Plaque in association with Alzheimer's disease, in which the target of UCL iGEM this year <a href="https://2013.igem.org/Team:UCL/Background/Alzheimers" target="_blank">Alzheimer's disease (AD)</a>. Matrix metallopeptidase 9 (MMP-9) was discovered to degrade Beta-Amyloid that can be potentially used to cure Alzheimer's disease.

Our Sponsors

TueSponsorsEppendorf.png 125px Invitrogen.jpg Geneart.jpg CSynBI.JPG